ZTS Zoetis Inc.
Stock · NYSE · United States · Healthcare · US98978V1035
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Zoetis Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
79.40 USD
-3.30%
52-week range
68.77 – 132.49
Dividend yield2.67%
Market cap32.3B
NowoTrade score
81 Grade A
Price history
Daily prices in USD.
Updated 08 Nov 2026 14:28. Information, not advice.
Results
Next results
11 Feb 2027
in 95 days · 08:00 · estimate 1.21
Last results
1.75 vs 1.51 estimated
05 Nov 2026 · Beat +15.8%
Beat the estimate
9 of 12
2 missed · 1 in line
Average surprise
+4.2%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 11 Feb 2027 08:00 | 1.21 | — | — | Upcoming |
| 05 Nov 2026 07:00 | 1.51 | 1.75 | +15.8% | Beat |
| 06 Aug 2026 07:00 | 1.85 | 1.87 | +1.0% | In line |
| 07 May 2026 07:00 | 1.62 | 1.53 | -5.3% | Miss |
| 12 Feb 2026 07:00 | 1.40 | 1.48 | +5.5% | Beat |
| 04 Nov 2025 07:00 | 1.62 | 1.70 | +4.8% | Beat |
| 05 Aug 2025 07:00 | 1.61 | 1.76 | +9.2% | Beat |
| 06 May 2025 07:00 | 1.40 | 1.48 | +5.8% | Beat |
| 13 Feb 2025 07:00 | 1.36 | 1.40 | +2.8% | Beat |
| 04 Nov 2024 07:00 | 1.46 | 1.58 | +8.0% | Beat |
| 06 Aug 2024 07:00 | 1.48 | 1.56 | +5.3% | Beat |
| 02 May 2024 07:00 | 1.34 | 1.38 | +3.2% | Beat |
| 13 Feb 2024 07:00 | 1.32 | 1.24 | -5.9% | Miss |
| 02 Nov 2023 07:00 | 1.36 | 1.36 | +0.4% | In line |
| 08 Aug 2023 07:00 | 1.31 | 1.41 | +8.0% | Beat |
| 04 May 2023 07:00 | 1.25 | 1.31 | +4.5% | Beat |
| 14 Feb 2023 07:00 | 1.15 | 1.15 | +0.3% | In line |
| 03 Nov 2022 07:00 | 1.24 | 1.21 | -2.1% | Miss |
| 04 Aug 2022 07:00 | 1.22 | 1.20 | -1.6% | Miss |
| 05 May 2022 07:00 | 1.22 | 1.32 | +8.0% | Beat |
| 15 Feb 2022 07:00 | 0.96 | 1.00 | +3.8% | Beat |
| 04 Nov 2021 07:00 | 1.11 | 1.25 | +12.5% | Beat |
| 05 Aug 2021 07:00 | 1.09 | 1.19 | +9.3% | Beat |
| 06 May 2021 07:00 | 1.04 | 1.26 | +21.6% | Beat |
| 16 Feb 2021 07:00 | 0.87 | 0.91 | +4.8% | Beat |
| 05 Nov 2020 07:00 | 0.92 | 1.10 | +20.2% | Beat |
| 06 Aug 2020 07:00 | 0.65 | 0.89 | +37.1% | Beat |
| 06 May 2020 08:00 | 0.87 | 0.95 | +9.3% | Beat |
| 13 Feb 2020 07:00 | 0.88 | 0.92 | +4.3% | Beat |
| 07 Nov 2019 07:00 | 0.89 | 0.94 | +6.2% | Beat |
| 06 Aug 2019 07:00 | 0.82 | 0.90 | +9.4% | Beat |
| 02 May 2019 07:00 | 0.79 | 0.88 | +11.6% | Beat |
| 14 Feb 2019 07:00 | 0.77 | 0.79 | +2.4% | Beat |
| 01 Nov 2018 07:00 | 0.77 | 0.83 | +7.4% | Beat |
| 02 Aug 2018 07:00 | 0.70 | 0.77 | +9.5% | Beat |
| 02 May 2018 07:00 | 0.69 | 0.75 | +8.1% | Beat |
| 15 Feb 2018 07:00 | 0.66 | 0.69 | +4.7% | Beat |
| 02 Nov 2017 07:00 | 0.62 | 0.65 | +4.0% | Beat |
| 08 Aug 2017 07:00 | 0.53 | 0.53 | +0.5% | In line |
| 04 May 2017 07:00 | 0.48 | 0.53 | +11.0% | Beat |
| 16 Feb 2017 07:00 | 0.45 | 0.47 | +3.8% | Beat |
| 02 Nov 2016 07:00 | 0.46 | 0.52 | +12.4% | Beat |
| 03 Aug 2016 07:00 | 0.44 | 0.49 | +10.6% | Beat |
| 04 May 2016 07:00 | 0.41 | 0.48 | +16.8% | Beat |
| 16 Feb 2016 07:00 | 0.39 | 0.43 | +11.2% | Beat |
| 03 Nov 2015 07:00 | 0.40 | 0.50 | +25.5% | Beat |
| 04 Aug 2015 07:00 | 0.38 | 0.43 | +13.2% | Beat |
| 05 May 2015 07:00 | 0.37 | 0.41 | +12.2% | Beat |
| 11 Feb 2015 07:00 | 0.36 | 0.40 | +12.4% | Beat |
| 04 Nov 2014 07:00 | 0.37 | 0.41 | +10.6% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 9.5B | +2.3% | 2.7B | 28.2% | 6.02 | +10.1% | 2.3B |
| 2024 | 9.3B | +8.3% | 2.5B | 26.9% | 5.47 | +7.9% | 2.3B |
| 2023 | 8.5B | +5.7% | 2.3B | 27.4% | 5.07 | +12.9% | 1.6B |
| 2022 | 8.1B | — | 2.1B | 26.2% | 4.49 | — | 1.3B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 07 Nov 2024 | 172.59 | 174.79 | 169.64 | 174.25 | +2.28% | 3,781,300 | |
| 06 Nov 2024 | 178.52 | 178.92 | 169.31 | 170.37 | -2.80% | 5,362,100 | |
| 05 Nov 2024 | 174.56 | 176.80 | 172.25 | 175.27 | +0.05% | 2,453,800 | |
| 04 Nov 2024 | 176.64 | 179.17 | 173.59 | 175.18 | -3.72% | 4,164,000 | |
| 01 Nov 2024 | 179.98 | 183.11 | 179.20 | 181.95 | +1.77% | 2,838,600 | |
| 31 Oct 2024 | 180.22 | 181.58 | 178.74 | 178.78 | -2.17% | 2,120,000 | 0.4320 |
| 30 Oct 2024 | 179.92 | 183.81 | 179.80 | 182.74 | +0.81% | 1,957,800 | |
| 29 Oct 2024 | 182.01 | 184.41 | 181.04 | 181.27 | -0.82% | 1,696,000 | |
| 28 Oct 2024 | 181.53 | 183.10 | 180.70 | 182.76 | +1.53% | 1,909,700 | |
| 25 Oct 2024 | 181.49 | 182.03 | 179.67 | 180.01 | -0.82% | 2,622,900 | |
| 24 Oct 2024 | 187.56 | 188.25 | 180.06 | 181.50 | -3.96% | 4,485,900 | |
| 23 Oct 2024 | 189.40 | 189.98 | 187.56 | 188.99 | -0.27% | 1,339,500 | |
| 22 Oct 2024 | 188.41 | 189.82 | 187.22 | 189.51 | +0.03% | 1,441,900 | |
| 21 Oct 2024 | 192.48 | 193.00 | 189.18 | 189.45 | -1.98% | 959,500 | |
| 18 Oct 2024 | 191.16 | 193.49 | 190.50 | 193.28 | +1.19% | 1,576,400 | |
| 17 Oct 2024 | 195.71 | 196.55 | 190.89 | 191.00 | -1.77% | 1,701,200 | |
| 16 Oct 2024 | 192.00 | 195.88 | 191.76 | 194.44 | +1.07% | 1,591,500 | |
| 15 Oct 2024 | 192.28 | 195.82 | 191.94 | 192.39 | -0.13% | 1,414,600 | |
| 14 Oct 2024 | 190.16 | 193.04 | 189.79 | 192.65 | +1.35% | 1,616,400 | |
| 11 Oct 2024 | 190.21 | 192.82 | 189.70 | 190.08 | -0.11% | 1,819,900 | |
| 10 Oct 2024 | 189.76 | 190.77 | 188.92 | 190.28 | +0.06% | 1,153,600 | |
| 09 Oct 2024 | 187.28 | 190.44 | 187.01 | 190.17 | +1.49% | 965,400 | |
| 08 Oct 2024 | 187.00 | 189.25 | 186.65 | 187.37 | +0.05% | 1,990,100 | |
| 07 Oct 2024 | 190.08 | 190.12 | 186.64 | 187.28 | -1.45% | 1,847,300 | |
| 04 Oct 2024 | 190.99 | 191.87 | 189.00 | 190.03 | -0.50% | 1,697,700 |
Page 21 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Zoetis (ZTS) Stock Price Drops After Q3 Earnings Margin Pressure (opens in a new tab) Simply Wall St. · 06 Nov 2026 23:10
- Zoetis: Quality Company Trading Cheap (opens in a new tab) SeekingAlpha · 06 Nov 2026 09:18
- Zoetis Inc. (ZTS) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 06 Nov 2026 05:24
- Zoetis: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 06 Nov 2026 03:07
- Zoetis Inc. 2026 Q3 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 06 Nov 2026 02:30
- Zoetis (ZTS) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 21:35
- No Greyhounds Here: Pet-Health Giant Zoetis Reverses 30% Monthlong Sprint (opens in a new tab) Investor's Business Daily · 05 Nov 2026 21:27
- Zoetis Inc. Reports Third Quarter 2026 Results and Updates Full Year 2026 Guidance (opens in a new tab) Fintel · 05 Nov 2026 18:21
- ZTS Q3 Earnings Top Estimates, 2026 Profit Outlook Improves, Stock Up (opens in a new tab) Zacks · 05 Nov 2026 17:29
- Zoetis Lifts Annual Outlook While Braces For Cautious Pet Economy (opens in a new tab) Benzinga · 05 Nov 2026 14:15
- Zoetis Adds To 21% Monthlong Run, Barking Up A Third-Quarter Beat (opens in a new tab) 05 Nov 2026 13:48
- Zoetis (ZTS) Reports Q3 Earnings: What Key Metrics Have to Say (opens in a new tab) Zacks · 05 Nov 2026 13:30
- Zoetis (NYSE:ZTS) posts better-than-expected sales in Q3 2026 (opens in a new tab) StockStory · 05 Nov 2026 12:58
- Zoetis (ZTS) Q3 Earnings and Revenues Top Estimates (opens in a new tab) Zacks · 05 Nov 2026 12:15
- Zoetis: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 05 Nov 2026 12:10
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 82.11 USD
- Market cap
- 32.3B
- Dividend yield
- 2.67%
- 5-year average yield
- 0.93%
- Payout ratio
- 35%
- Last dividend
- 0.5300 USD · 30 Oct 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 30 Oct 2026 | 0.5300 USD |
| 20 Jul 2026 | 0.5300 USD |
| 20 Apr 2026 | 0.5300 USD |
| 20 Jan 2026 | 0.5300 USD |
| 31 Oct 2025 | 0.5000 USD |
| 18 Jul 2025 | 0.5000 USD |
| 21 Apr 2025 | 0.5000 USD |
| 21 Jan 2025 | 0.5000 USD |
| 31 Oct 2024 | 0.4320 USD |
| 18 Jul 2024 | 0.4320 USD |
| 18 Apr 2024 | 0.4320 USD |
| 18 Jan 2024 | 0.4320 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 11.1 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 24.3 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 15.0 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 15.0 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 10.0 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 3.8 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 13.5× | Good | 30.3× |
| P/E (forward) | 12.4× | Good | 14.94× |
| Price / book | 9.8× | Weak | 3.81× |
| Price / sales | 3.4× | Fair | 3.19× |
| EV / EBITDA | 9.92× | Good | 12.63× |
| Free cash flow yield | 6.4% | Good | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 71.6% | Good | 58.6% |
| Operating margin | 38.2% | Good | 7.8% |
| Net margin | 26.4% | Good | 2.8% |
| Return on equity | 57.6% | Good | 5.7% |
| Return on assets | 14.9% | Good | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 5.4% | Fair | 10.8% |
| EPS growth / year | 10.3% | Good | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 2.8× | Weak | 0.48× |
| Net debt / EBITDA | 1.92× | Fair | 1.58× |
| Interest cover | 16.2× | Good | 2.76× |
| Current ratio | 2.35× | Good | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 35.2% | Good | 0% |
| Payout of free cash flow | 43.3% | Good | 28.9% |
| Payout of free cash flow (3 years) | 38.2% | Good | — |
| Dividend growth / year | 19.3% | Good | 7.1% |
| Years of rising dividends | 11 | Good | 3 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow ZTS and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.